Sign up to save your podcasts
Or
Share Carcinogen In Zantac Triggers FDA Probe
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Carcinogen In Zantac Triggers FDA Probe
Drug regulators in the U.S. and Europe are looking into the safety of the heartburn medication Zantac. Bloomberg’s Anna Edney reports.
View all episodes
By Audacy
4.2
55 ratings
Drug regulators in the U.S. and Europe are looking into the safety of the heartburn medication Zantac. Bloomberg’s Anna Edney reports.